Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Prevention of Postoperative Nausea and Vomiting
NCT00090246Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- May 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of aprepitant in postoperative nausea and vomiting (PONV), sponsored by Merck & Co.. Started May 2004; status: completed.
02
Drugs
aprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT00090246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090246.